297 related articles for article (PubMed ID: 17454193)
1. Comparison of diagnostic criteria for polycythaemia vera.
Turkington RC; Arnold EC; Percy MJ; Ranaghan LA; Cuthbert RJ; McMullin MF
Hematology; 2007 Apr; 12(2):123-30. PubMed ID: 17454193
[TBL] [Abstract][Full Text] [Related]
2. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
3. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
4. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract][Full Text] [Related]
7. Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.
Alvarez-Larrán A; Angona A; Ancochea A; García-Pallarols F; Fernández C; Longarón R; Bellosillo B; Besses C
Eur J Haematol; 2016 Jan; 96(1):83-9. PubMed ID: 25810304
[TBL] [Abstract][Full Text] [Related]
8. Masked polycythemia vera diagnosed according to WHO and BCSH classification.
Barbui T; Thiele J; Carobbio A; Gisslinger H; Finazzi G; Rumi E; Luigia Randi M; Vannucchi AM; Gisslinger B; Müllauer L; Ruggeri M; Rambaldi A; Tefferi A
Am J Hematol; 2014 Feb; 89(2):199-202. PubMed ID: 24166817
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
Rossi D; Cortini F; Deambrogi C; Barbieri C; Cerri M; Franceschetti S; Conconi A; Capello D; Gaidano G
Leuk Res; 2007 Jan; 31(1):97-101. PubMed ID: 16620973
[TBL] [Abstract][Full Text] [Related]
10. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.
Johansson PL; Safai-Kutti S; Kutti J
Br J Haematol; 2005 Jun; 129(5):701-5. PubMed ID: 15916693
[TBL] [Abstract][Full Text] [Related]
11. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
[TBL] [Abstract][Full Text] [Related]
13. Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.
Ganly P; Hanrahan V; Baker B; Romeril K
Am J Hematol; 2007 Jan; 82(1):80-2. PubMed ID: 16924638
[TBL] [Abstract][Full Text] [Related]
14. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.
Barbui T; Thiele J; Carobbio A; Guglielmelli P; Rambaldi A; Vannucchi AM; Tefferi A
Am J Hematol; 2014 Jun; 89(6):588-90. PubMed ID: 24535932
[TBL] [Abstract][Full Text] [Related]
15. JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.
Yoshinaga K; Mori N; Wang YH; Tomita K; Shiseki M; Motoji T
Int J Hematol; 2008 Jul; 88(1):82-87. PubMed ID: 18528646
[TBL] [Abstract][Full Text] [Related]
16. A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).
Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):81-6. PubMed ID: 20425336
[TBL] [Abstract][Full Text] [Related]
17. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
18. Beyond Hemoglobin: When and How to Work Up Possible Polycythemia Vera.
Shaw G; Berg R
Clin Med Res; 2020 Mar; 18(1):11-20. PubMed ID: 31582417
[TBL] [Abstract][Full Text] [Related]
19. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
20. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
Jakovic L; Gotic M; Gisslinger H; Soldatovic I; Sefer D; Tirnanic M; Lekovic D; Jovanovic MP; Schalling M; Gisslinger B; Beham-Schmid C; Simonitsch-Klupp I; Thiele J
Ann Hematol; 2018 Sep; 97(9):1581-1590. PubMed ID: 29717365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
